search Result

Increased scrutiny by US FDA: A boon or bane Indian pharmaceutical sector

Even with the surge in USFDA-approved manufacturing sites in India, the proportion of Official Action Initiated (OAI) observations by the USFDA has stayed consistent at 10% of total inspections in CY23. Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back